Regarding AMD diagnosis, epigenomic research [97] has revealed that hypomethylation of the IL17RC promoter in AMD patients (n = 202) compared to controls (n = 96) can result in elevated concentrations of IL17RC proteins and messenger RNAs in the peripheral blood as well as in the affected retina and choroid. The gene discussed is IL17RC; the disease is age-related macular degeneration.